The first half of the trial focused on the transaction’s effect on the national insurance market, including large employers with employees in several states. If the Department of Justice’s argument — that the acquisition would limit national market competition and raise prices for consumers — proves convincing, Judge Jackson will bypass the second phase of the trial. The second phase, which concerns the deal’s effect on small market competition, is scheduled to begin Dec. 12.
During the first phase of the trial, court testimonies revealed Indianapolis-based Anthem and Bloomfield, Conn.-based Cigna hold several disagreements over their proposed deal. Testimonies from Anthem CEO Joseph Swedish and Cigna CEO David Cordani show Cigna officials questioned Anthem’s proposed strategy after acquiring Cigna. Additionally, Anthem officials attempted to push the deal forward unilaterally, as Cigna stopped working with Anthem on issues related to the proposed purchase.
However, Mr. Swedish said the disagreements will not halt the forward progression of the deal should the court rule in favor of the insurers, arguing the acquisition will make Anthem more innovative, efficient and curb costs.
More articles on payer issues:
The Ohio State University Wexner Medical Center joins Anthem BCBS network
BCBS of Massachusetts to receive $40M in risk adjustment payments
Pennsylvania insurance commissioner launches health plan comparison tool
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.